Top

Published in:

Open Access 01-12-2018 | Commentary

Lipidomics: a promising cancer biomarker

Authors: Furong Yan, Hong Zhao, Yiming Zeng

Published in: Clinical and Translational Medicine | Issue 1/2018

Abstract

The prevention, diagnosis and targeted therapies of cancer are important in cancer controlling and treatment. The present challenge about cancer biomarker still remains in identifying the special biomarkers for predicting cancer risk and assessing patient’s response during anticancer treatment. Lipidomics, in simple definition is the quantification of all lipids in a confined biological entity. Lipids play roles in membrane structure, energy storage, and signal transduction as well as in human cancers. Previous researches indicated that lipids may serve as a promising biomarker in the early diagnoses and individualized treatment of cancer.

Wenk MR (2005) The emerging field of lipidomics. Nat Rev Drug Discov 4(7):594–610CrossRefPubMed

Perrotti F, Rosa C, Cicalini I, Sacchetta P, Del Boccio P, Genovesi D et al (2016) Advances in lipidomics for cancer biomarkers discovery. Int J Mol Sci https://doi.org/10.3390/ijms17121992 PubMedPubMedCentralCrossRef

Sutphen R, Xu Y, Wilbanks GD, Fiorica J, Grendys EC Jr, LaPolla JP et al (2004) Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol Biomarkers Prevent 13(7):1185–1191

Lin L, Ding Y, Wang Y, Wang Z, Yin X, Yan G et al (2017) Functional lipidomics: palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism. Hepatology 66(2):432–448CrossRefPubMed

Giskeodegard GF, Hansen AF, Bertilsson H, Gonzalez SV, Kristiansen KA, Bruheim P et al (2015) Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia. Br J Cancer 113(12):1712–1719CrossRefPubMedPubMedCentral

Babahosseini H, Roberts PC, Schmelz EM, Agah M (2012) Roles of bioactive sphingolipid metabolites in ovarian cancer cell biomechanics. In: Conference proceedings: annual international conference of the IEEE engineering in medicine and biology society IEEE engineering in medicine and biology society annual conference. pp. 2436–9

Nagahashi M, Tsuchida J, Moro K, Hasegawa M, Tatsuda K, Woelfel IA et al (2016) High levels of sphingolipids in human breast cancer. J Surg Res 204(2):435–444CrossRefPubMedPubMedCentral

Van Brocklyn JR (2007) Sphingolipid signaling pathways as potential therapeutic targets in gliomas. Mini Rev Med Chem 7(10):984–990CrossRefPubMed

Yang MH, Rampal S, Sung J, Choi YH, Son HJ, Lee JH et al (2013) The association of serum lipids with colorectal adenomas. Am J Gastroenterol 108(5):833–841CrossRefPubMed

10.

Lv JGD, Zhang Y, Wu D, Shen L, Wang X (2018) Heterogeneity of lipidomic profiles among lung cancer subtypes of patients. J Cell Mol Med. https://doi.org/10.1111/JCMM.13782 CrossRefPubMedPubMedCentral

11.

Wang X (2018) Clinical trans-omics: an integration of clinical phenomes with molecular multiomics. Cell Biol Toxicol 34(3):163–166CrossRefPubMed

12.

Harkewicz R, Dennis EA (2011) Applications of mass spectrometry to lipids and membranes. Annu Rev Biochem 80:301–325CrossRefPubMedPubMedCentral

13.

Yang L, Cui X, Zhang N, Li M, Bai Y, Han X et al (2015) Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers. Anal Bioanal Chem 407(17):5065–5077CrossRefPubMed

14.

Shen S, Yang L, Li L, Bai Y, Cai C, Liu H (2017) A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer. J Chromatogr B 1068–1069:41–48CrossRef

15.

Zhou X, Mao J, Ai J, Deng Y, Roth MR, Pound C et al (2012) Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics. PLoS ONE 7(11):e48889CrossRefPubMedPubMedCentral

16.

Kim H, Min HK, Kong G, Moon MH (2009) Quantitative analysis of phosphatidylcholines and phosphatidylethanolamines in urine of patients with breast cancer by nanoflow liquid chromatography/tandem mass spectrometry. Anal Bioanal Chem 393(6–7):1649–1656CrossRefPubMed

17.

Saliba AE, Vonkova I, Gavin AC (2015) The systematic analysis of protein–lipid interactions comes of age. Nat Rev Mol Cell Biol 16(12):753–761CrossRefPubMed

18.

Bagam P, Singh DP, Inda ME, Batra S (2017) Unraveling the role of membrane microdomains during microbial infections. Cell Biol Toxicol 33(5):429–455CrossRefPubMedPubMedCentral

19.

Shevchenko A, Simons K (2010) Lipidomics: coming to grips with lipid diversity. Nat Rev Mol Cell Biol 11(8):593–598CrossRefPubMed

Title: Lipidomics: a promising cancer biomarker
Authors: Furong Yan
Hong Zhao
Yiming Zeng
Publication date: 01-12-2018
Publisher: Springer Berlin Heidelberg
Published in: Clinical and Translational Medicine / Issue 1/2018
Electronic ISSN: 2001-1326
DOI: https://doi.org/10.1186/s40169-018-0199-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Lipidomics: a promising cancer biomarker

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Alk5/Runx1 signaling mediated by extracellular vesicles promotes vascular repair in acute respiratory distress syndrome

The impact of modifiable risk factor reduction on childhood asthma development

Correction to: A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors

Correlation analysis of monocyte subsets and insulin resistance considering fetuin-A involvement in patients with type 2 diabetes

Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients

Comparison of paired human nasal and bronchial airway epithelial cell responses to rhinovirus infection and IL-13 treatment